Alan W. Dunton

Alan W. Dunton has an extensive work experience in the pharmaceutical industry. Alan W. started their career in 2006 as the Principal and Founder of Danerius, LLC. Alan W. then served as President and CEO of Panacos Pharmaceuticals, Inc. from 2007 to 2009. In 2011, they became a Director at Oragenics, Inc. and Palatin Technologies. Alan W. also served as the Non-Executive Chairman of the Board at EpiCept Corporation in 2012. Additionally, they held roles as a Director at MediciNova, Inc. from 2006 to 2011, and at Sancilio & company from 2012 to 2015. In 2015, they became the Senior Vice President of Research and Development at Purdue Pharma, LLP, where they worked until 2018. Currently, they are the Director of Cytogel Pharma, LLC. Alan W. Dunton has also served on the Board of Directors of Targacept, Inc. from 2006 to 2015.

Alan W. Dunton obtained an M.D. degree in Internal Medicine from New York University School of Medicine, where they studied from 1976 to 1980. Alan W. also holds a Doctor of Medicine (M.D.) degree from the same institution. Additionally, they are a Diplomate of the American Board of Internal Medicine, although the exact year of certification attainment is unknown.